Brand Name Re-Fenac
Type Ophthalmic Solution
Weight 0.09%
Generic Bromfenac Sodium
Manufacturer Reman Drug Laboratories Ltd.
Price 5 ml drop: ৳ 100.00

About Re-Fenac

Re-Fenac Ophthalmic Solution (Reman Drug Laboratories Ltd.) is a brand medicine containing the generic Bromfenac Sodium . Current listed price in Bangladesh: 5 ml drop: ৳ 100.00.

Medical information for Re-Fenac Ophthalmic Solution 0.09%

Uses, dosage, side effects, and safety details below apply to Re-Fenac Ophthalmic Solution 0.09% (generic: Bromfenac Sodium). This is general information — consult a doctor before use.

Introduction

Bromfenac is a nonsteroidal anti-inflammatory drug (NSAID) for ophthalmic use. Ophthalmic NSAIDs are becoming a cornerstone for the management of ocular pain and inflammation. Their well-characterized anti-inflammatory activity, analgesic property, and established safety record have also made NSAIDs an important tool to optimize surgical outcomes.

Uses

Bromfenac is an NSAID used to treat postoperative pain and inflammation of the eye.

For the treatment of postoperative inflammation in patients who have undergone cataract extraction.

Associated Conditions

  • Eye Pain
  • Ocular Inflammation

Pharmacodynamics

Bromfenac ophthalmic solution is a sterile, topical, nonsteroidal anti-inflammatory drug (NSAID) for ophthalmic use.

Mechanism of Action

The mechanism of its action is thought to be due to its ability to block prostaglandin synthesis by inhibiting cyclooxygenase 1 and 2. Prostaglandins have been shown in many animal models to be mediators of certain kinds of intraocular inflammation. In studies performed in animal eyes, prostaglandins have been shown to produce disruption of the blood-aqueous humor barrier, vasodilation, increased vascular permeability, leukocytosis, and increased intraocular pressure.

Absorption

The plasma concentration of bromfenac following ocular administration in humans is unknown.

Food Interactions

No interactions found.

Dosage

For the treatment of postoperative inflammation in patients who have undergone cataract extraction, one drop of ophthalmic solution should be applied to the affected eye(s) once daily beginning 1 day prior to cataract surgery, continued on the day of surgery, and through the first 14 days of the postoperative period.

Medical review

Last reviewed: 24 Jul 2026

Medically reviewed by:

This is general information, not personal medical advice. Consult a doctor before taking any medicine.

Taking medicines without doctor's advice can cause long-term problems.
Dr. Md. Jamal Uddin

Dr. Md. Jamal Uddin

Orthopedic, Trauma & Vascular Surgery Specialist

Call Doctor
Dr. Nadia Nusrat

Dr. Nadia Nusrat

Child, Newborn & Adolescent Specialist

Call Doctor
Dr. Shoma Sharker

Dr. Shoma Sharker

Diabetes & Hormone Specialist

Call Doctor
Related Medicines